NCT07103278View on ClinicalTrials.gov

A Clinical Trial to Evaluate the Safety and the Pharmacokinetics of AD-116 Compared to AD-1161 in Healthy Adult Male Volunteers

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

44

Participants

Timeline

Start Date

December 31, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions

Benign Prostatic Hyperplasia

Interventions

DRUG

AD-116

AD-116 Oral Tablet

DRUG

AD-1161

AD-1161 Oral Capsule

All Listed Sponsors

lead

Addpharma Inc.

INDUSTRY